These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 7041587)
1. Hemodynamic effects of captopril in patients with severe chronic heart failure. LeJemtel TH; Keung E; Frishman WH; Ribner HS; Sonnenblick EH Am J Cardiol; 1982 Apr; 49(6):1484-8. PubMed ID: 7041587 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of captopril in low-renin congestive heart failure: importance of sustained reactive hyperreninemia in distinguishing responders from nonresponders. Packer M; Medina N; Yushak M Am J Cardiol; 1984 Oct; 54(7):771-7. PubMed ID: 6091434 [TBL] [Abstract][Full Text] [Related]
3. A cooperative multicenter study of captopril in congestive heart failure: hemodynamic effects and long-term response. Chatterjee K; Parmley WW; Cohn JN; Levine TB; Awan NA; Mason DT; Faxon DP; Creager M; Gavras HP; Fouad FM Am Heart J; 1985 Aug; 110(2):439-47. PubMed ID: 3895877 [TBL] [Abstract][Full Text] [Related]
4. Hemodynamic and regional blood flow response to captopril in congestive heart failure. Levine TB; Olivari MT; Cohn JN Am J Med; 1984 May; 76(5B):38-42. PubMed ID: 6375361 [TBL] [Abstract][Full Text] [Related]
5. Hemodynamic patterns of response during long-term captopril therapy for severe chronic heart failure. Packer M; Medina N; Yushak M; Meller J Circulation; 1983 Oct; 68(4):803-12. PubMed ID: 6352079 [TBL] [Abstract][Full Text] [Related]
6. Quantitative differences in the hemodynamic effects of captopril and nitroprusside in severe chronic heart failure. Packer M; Meller J; Medina N; Yushak M Am J Cardiol; 1983 Jan; 51(1):183-8. PubMed ID: 6336876 [TBL] [Abstract][Full Text] [Related]
7. Endogenous prostaglandin E2 metabolite levels, renin-angiotensin system and catecholamines versus acute hemodynamic response to captopril in chronic congestive heart failure. Silberbauer K; Punzengruber C; Sinzinger H Cardiology; 1983; 70(6):297-307. PubMed ID: 6370431 [TBL] [Abstract][Full Text] [Related]
8. Angiotensin inhibition in severe heart failure: acute central and limb hemodynamic effects of captopril with observations on sustained oral therapy. Faxon DP; Halperin JL; Creager MA; Gavras H; Schick EC; Ryan TJ Am Heart J; 1981 May; 101(5):548-56. PubMed ID: 7013458 [TBL] [Abstract][Full Text] [Related]
9. Treatment of chronic congestive heart failure with captopril, an oral inhibitor of angiotensin-converting enzyme. Davis R; Ribner HS; Keung E; Sonnenblick EH; LeJemtel TH N Engl J Med; 1979 Jul; 301(3):117-21. PubMed ID: 221810 [TBL] [Abstract][Full Text] [Related]
10. Acute and long-term response to an oral converting-enzyme inhibitor, captopril, in congestive heart failure. Levine TB; Franciosa JA; Cohn JN Circulation; 1980 Jul; 62(1):35-41. PubMed ID: 6247102 [No Abstract] [Full Text] [Related]
11. The contributions of sympathetic tone and the renin-angiotensin system to severe chronic congestive heart failure: response to specific inhibitors (prazosin and captopril). Kluger J; Cody RJ; Laragh JH Am J Cardiol; 1982 May; 49(7):1667-74. PubMed ID: 7044087 [TBL] [Abstract][Full Text] [Related]
12. Immediate and sustained hemodynamic and clinical improvement in chronic heart failure by an oral angiotensin-converting enzyme inhibitor. Ader R; Chatterjee K; Ports T; Brundage B; Hiramatsu B; Parmley W Circulation; 1980 May; 61(5):931-7. PubMed ID: 6244906 [TBL] [Abstract][Full Text] [Related]
13. Hemodynamic responses to combined therapy with captopril and hydralazine in patients with severe heart failure. Massie BM; Packer M; Hanlon JT; Combs DT J Am Coll Cardiol; 1983 Aug; 2(2):338-44. PubMed ID: 6345633 [TBL] [Abstract][Full Text] [Related]
14. Hemodynamic and clinical significance of the pulmonary vascular response to long-term captopril therapy in patients with severe chronic heart failure. Packer M; Lee WH; Medina N; Yushak M J Am Coll Cardiol; 1985 Sep; 6(3):635-45. PubMed ID: 2993397 [TBL] [Abstract][Full Text] [Related]
15. Coronary hemodynamic effects of angiotensin inhibition by captopril and teprotide in patients with congestive heart failure. Halperin JL; Faxon DP; Creager MA; Bass TA; Melidossian CD; Gavras H; Ryan TJ Am J Cardiol; 1982 Nov; 50(5):967-72. PubMed ID: 6182786 [TBL] [Abstract][Full Text] [Related]
16. Haemodynamic and neurohumoral response to exercise in patients with congestive heart failure treated with captopril. Creager MA; Faxon DP; Weiner DA; Ryan TJ Br Heart J; 1985 Apr; 53(4):431-5. PubMed ID: 3885981 [TBL] [Abstract][Full Text] [Related]
17. Comparative immediate hemodynamic and hormonal effects of amrinone and captopril in patients with severe chronic heart failure. Packer M; Medina N; Yushak M Am J Med Sci; 1986 Jan; 291(1):8-15. PubMed ID: 3510545 [TBL] [Abstract][Full Text] [Related]
18. Captopril in refractory heart failure: clinical and hemodynamic observations. Abinader EG; Sharif D; Rosenfeld T; Malouf S Cardiology; 1983; 70(6):326-32. PubMed ID: 6370433 [TBL] [Abstract][Full Text] [Related]
19. Redistribution of regional blood flow following angiotensin-converting enzyme inhibition. Comparison of normal subjects and patients with heart failure. Faxon DP; Creager MA; Halperin JL; Bernard DB; Ryan TJ Am J Med; 1984 May; 76(5B):104-10. PubMed ID: 6203405 [TBL] [Abstract][Full Text] [Related]
20. Sustained hemodynamic response to flosequinan in patients with heart failure receiving angiotensin-converting enzyme inhibitors. Gottlieb SS; Kukin ML; Penn J; Fisher ML; Cines M; Medina N; Yushak M; Taylor M; Packer M J Am Coll Cardiol; 1993 Oct; 22(4):963-7. PubMed ID: 8409070 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]